Transcatheter Aortic Valve Implantation (TAVI) for Native Aortic Valve Regurgitation 　- A Systematic Review.

CONCLUSIONS: TAVI demonstrates acceptable safety and efficacy in high-risk patients with severe NAVR. Second-generation valves may afford a similar safety profile with improved device success. Dedicated studies are needed to definitively establish the efficacy of TAVI in this population.
PMID: 29311499 [PubMed - as supplied by publisher]

Source: Circulation Journal - December 28, 2017 Category: Cardiology Authors: Yousef A, MacDonald Z, Simard T, Russo JJ, Feder J, Froeschl MV, Dick A, Glover C, Burwash IG, Latib A, Rodés-Cabau J, Labinaz M, Hibbert B Tags: Circ J Source Type: research